Status:
COMPLETED
The Headache Inducing Effects of Cilostazol on Migraine Patients
Lead Sponsor:
Danish Headache Center
Conditions:
Migraine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.
Eligibility Criteria
Inclusion
- Diagnosed with migraine without aura according to the IHS criteria from 2004.
- Healthy besides migraine
Exclusion
- Tension-type headache more than 3 days per month
- Other types of primary headaches
- Pregnancy
- History of vascular diseases or psychiatric diseases.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01841827
Start Date
April 1 2013
End Date
June 1 2013
Last Update
June 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Headache Center & Department of Neurology
Copenhagen, Glostrup, Denmark, 2600